Diabetes Technology Meeting

Thursday, November 19, 2020

Virtual Poster Session

Session A

Moderators:

Shashank Joshi, MD, DM, FICP, FACP(USA), FACE(USA), FRCP(Lon,Glsg & Edin)
Lilavati Hospital and Research Centre, Mumbai, India

Julia Mader, MD, PhD
Medical University of Graz, Graz, Austria

8:30

Impact of the MiniMed™ AHCL system on post-prandial glucose after a missed meal bolus in adolescents and adults with type 1 diabetes (T1D)

Jennifer Sherr, MD, PhD et al.

8:34

Individualized Linear Models for Glucose Prediction: Parametric vs. Non-Parametric Identification

Simone Faccioli, MSc et al.

8:38

Classification of Daily Continuous Glucose Monitoring (CGM) Profiles in Type 1 Diabetes Using Layered Clustering and Clinical Metrics

Mahdi Shafiei, PhD et al.

8:42

Pulsatile Insulin Treatment as  a Treatment Option for Patients with Type 2 Diabetes and Stage III Kidney Failure – Results from a Pilot Study

Andreas Pfützner, MD, PhD et al.

8:46

The Burden of Hypoglycemia during Real-World Conditions

Felix Aberer, MD et al.

8:50

A New Model for Mealtime Insulin Dosing in Type 1 Diabetes: Retrospective Validation on CTR3 Dataset

Giulia Noaro, MSc et al.

8:54

Q & A / Panel Discussion

Session B

Moderators:

John Nolan, MD, FRCPI, FRCP(Ed), FTCD (hon)
Trinity College Dublin, Dublin, Ireland

Gerry Rayman, MD, FRCP
The Ipswich Diabetes Centre Ipswich Hospital, Ipswich, UK

9:15

Predicting Blood Glucose Levels Using CNN-LSTM Neural Networks

Mehrad Jaloli, MSc et al.

9:19

Determining the Optimal Duration of a Clinical Trial Having Time-in-ranges as Final Endpoints

Nunzio Camerlingo, MSc et al.

9:23

Highly Miniaturized, Low Power CMOS ASIC for Long-Term, Needle-Implantable CGMs

Raja Hari Gudlavalleti, MS et al.

9:27

Expected Variability in Estimated Insulin Secretion from C-peptide using Van Cauter Kinetic Parameters

Jennifer J. Ormsbee, MSc et al.

9:31

Preliminary Assessment of a Mass Manufacturable Point-of-Care Insulin Sensor

Madison Strong, NONE et al.

9:35

Intravenous Automated Blood Glucose Control with No Meal Announcement. A Prospective Time-in-Range In Silico Study

Adrian Tarniceriu, PhD et al.

9:39

Q & A / Panel Discussion

Session C

Moderators:

Lori Laffel, MD, MPH
Joslin Diabetes Center Harvard Medical School, Boston, Massachusetts, USA

Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, Maryland, USA

10:00

Variations in Time in Range Assessed by CGM in the Early COVID-19 Pandemic

Joost van der Linden, PhD et al.

10:04

A Massive Open Online Course for Type 2 Diabetes Self-Management: Adapting Education in the COVID-19 Era

Scott Mackenzie, BMSc (Hons) MBChB et al.

10:08

Use of the Sencell Osmotic Pressure-Based Glucose Sensor in a Standard Needle Sensor Environment

Andreas Pfützner, MD, PhD et al.

10:12

Insulin Cost-Savings Comparison: 7-Day Extended Wear Infusion Set with Medtronic Pump vs. 2-3 Day Wear Infusion Set with Non-Medtronic Pump

Sarnath Chattaraj, PhD et al.

10:16

Role of Site Selection & Cannula Length in Insulin Infusion Set Performance

Gina Zhang, PhD et al.

10:20

Insulin, Not the Preservative m-Cresol, Instigates Loss of Infusion Site Patency Over Extended Durations of CSII in Diabetic Swine

Monica Swinney, PhD et al.

10:24

Q & A / Panel Discussion

Session D

Moderators:

Sanjoy Dutta, PhD
Juvenile Diabetes Research Foundation, New York, New York. USA

Boris Mankovsky, MD, PhD
Institute of Endocrinology, Kiev, Ukraine

10:45

Persistent Hyperglycemia in Extremely Low Birth Weight Premature Infants

Jennifer Knopp, PhD et al.

10:49

Significant Reduction in Time-Below-Range (Hypoglycemia) in People with Type 1 Diabetes using an Advanced Hybrid Closed Loop System

Lars Mueller, PhD et al.

10:53

The Effect of a Digital Therapeutic Platform on Glycemic Control in Adults above Age 65 with Type 2 Diabetes

Yifat Hershcovitz, PhD et al.

10:57

Differences in Perceived Quality of Sleep and Satisfaction with Insulin Delivery Device in People with Diabetes

Harsimran Singh, PhD et al.
Oral Presentation by Steph Habif, EdD, MS

11:01

Smart Insulin Pens Allow Correction Doses Between Meals as Needed Without Compromising Time Below Range

Madison Smith, PhD, RN, CDCES et al.

11:05

The Extended Wear Infusion Set- A Design for Plastic Waste Reduction

Hsi Fusselman, MS et al.

11:09

Q & A / Panel Discussion

Session E

Moderators:

Amisha Wallia, MD, MS
Northwestern Unviersity, Chicago, Illinois, USA

Jenise Wong, MD, PhD
UCSF, San Francisco, California, USA

11:30

Diminished Weekday/Weekend Differences in Glycemic Control in the COVID-19 Pandemic

Robert Dowd, BS et al.

11:34

The Impact of a Prolonged Lockdown and Use of Telemedicine on Glycemic Control in People with Type 1 Diabetes During the COVID-19 Outbreak in Saudi Arabia

Sahar Alharthi, MBBS et al.

11:38

Glycemic Outcomes with Adjustable Settings in the Advanced Hybrid Closed-loop (AHCL) System-Pivotal Trial

Anirban Roy, PhD et al.

11:42

Deteriorating Glucose Control in Patients With Diabetes (PWD) after Disengagement From A Mobile Health (mHealth) App

Sarine Babikian, PhD et al.
Oral Presentation by Mark Clements, MD, PhD

11:46

Simulation Platform Development for Diabetes and Technology Self-Management

Eileen Faulds, PhD, MS, RN et al.

11:50

Early Insights from a Digitally Enhanced Diabetes Self-Management Education and Support Program

Folasade Wilson-Anumudu, MPH et al.

11:54

Q & A / Panel Discussion

Session F

Moderators:

Francisco Pasquel, MD, MPH
Emory University, Atlanta, Georgia, USA

Louis Philipson, MD, PhD
University of Chicago, Chicago, Illinois, USA

12:15

Regional COVID-19 Disease Burden and Individual Changes in Glycemic Control

Joost van der Linden, PhD et al.

12:19

Performance of a Factory-Calibrated Continuous Glucose Monitoring (CGM) System with a Retuned Algorithm

Xiaohe Zhang, MS et al.
Oral Presentation by Rebecca Harvey Towers, PhD

12:23

Closed-Loop Insulin Delivery in Adults with Highly Unstable Type 1 Diabetes Can Outperform Suspend-Before-Low Insulin Pump Technology, a 16-Week Randomized Crossover Trial

Pierre Yves Benhamou, MD et al.

12:27

Cost-utility of an online education platform and diabetes personal health record: analysis over ten years

Scott Cunningham, PhD et al.

12:31

Web-based Simulation Tool for Self-Management Support in Type 1 Diabetes

Patricio Colmegna, PhD et al.

12:35

Predicting Success with a Diabetes mHealth Application from Early Usage Data

Maya Mudambi, MCIT, BA et al.

12:39

Q & A / Panel Discussion